![](https://endpts.com/wp-content/uploads/2021/11/Qiang-Peter-Ding-scaled.jpg)
Peter Ding, Allorion Therapeutics co-founder and CEO
A fledgling transpacific biotech grabs a launch round to dive into oncology and autoimmune research
Precision-med biotech Allorion Therapeutics is expanding — and now has tens of millions of dollars more to work with.
The Natick, MA-based company announced in a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.